Description VisionGate, Inc., founded by our CEO Dr. Alan Nelson, is a clinical stage oncology pharmaceutical and diagnostics company with a focus on saving lives by developing new products for the early detection, prevention and treatment of cancer, including lung cancer and lung dysplasia.